scorecardresearch
Wednesday, October 2, 2024
TopicCOVID-19

Topic: COVID-19

How Bengal’s Covid-19 toll went up nearly 4 times in 24 hours after Modi govt probe

The West Bengal govt said Friday that 57 Covid-19 patients had died in the state, but clarified that most of these were the result of ‘comorbid conditions’.

India would have seen over 1 lakh cases without lockdown: Covid-19 panel head VK Paul

At a media briefing, NITI Aayog member V.K. Paul said doubling rate of Covid-19 in India is almost ten days now — from three days on 21 March.

How one grocer infected 35 people, made Tughlaqabad Extension Delhi’s 3rd-biggest hotspot

The grocer’s extended family occupies more than half the houses in gali number 26, and of the 35 cases detected here, almost 90 per cent are related to him.

World awaits Alphonsos, but the mangoes are stuck in Konkan lockdown

Apart from Alphonso mango, the lockdown in Konkan region has brought the cashew harvesting season to a standstill due to lack of labour.

Armed forces put non-operational expenditure on hold amid Covid-19 fund crunch

Defence Minister Rajnath Singh also tells top commanders to ensure operational preparedness, so that ‘adversary’ can’t exploit current situation.

How use of Chinese rapid testing Covid-19 kits created panic in a Kashmir village

Doctors had declared a man in a Pampore village ‘weak positive’ for Covid-19 after his samples were tested using rapid antibody testing kits.

One in five New York City residents tests positive for coronavirus antibody, shows survey

A survey of over 3,000 people in New York State show that 13.9 per cent had antibodies against Covid-19, meaning they were exposed to the virus without knowing.

Remdesivir fails to treat Covid in China trial, drug maker says too soon to draw conclusion

The antiviral remdesivir was earlier reported to show promising results in curing critically ill patients. Drug maker Gilead Sciences said investigators were still analysing test data.

Chinese firms say ready to cooperate with India’s probe into ‘malfunctioning’ Covid test kits

The clarification from Guangzhou Wondfo Biotech & Zhuhai Livzon Diagnostics came days after India briefly halted the use of antibody tests amid ‘discrepant results’. 

Plasma therapy on Delhi Covid-19 patients yields positive results, say Kejriwal & top doctor

Delhi CM Arvind Kejriwal and ILBS director Dr S.K. Sarin say plasma therapy has worked quickly on 4 patients at LNJP Hospital, calling it a ray of hope.

On Camera

Indian industry in Bangladesh is staring at a void. New Delhi must give line of credit to Dhaka

For New Delhi, SAFTA and CEPA will be critical. Such frameworks could institutionalise economic ties with Bangladesh, making them resilient to political disruptions.


Even as SEBI lays down new curbs on F&O market, discount brokerages are changing business models

SEBI Tuesday unveiled rules to curtail retail participation in derivatives market. Options premia to be collected upfront from options buyer effective 1 Feb 2025.

‘No drone bombs or infiltration’, Army Chief says ‘battle of narratives’ must be controlled in Manipur

Chief of Army Staff General Upendra Dwivedi says the Manipur conflict was triggered by a rumour and that the situation may be ‘stable today, but it is tense’.

Islam doesn’t kill democracy. The army-Islam combo does

How come Indonesia, Malaysia, Turkey and Sri Lanka remain constitutional, democratic and stable despite Islam and Buddhism respectively, but Pakistan, Bangladesh and Myanmar don’t?